Market Place
Sourcing Support
All News #Library
Generics
Accord Pharma US Reintroduces Hydrochlorothiazide Tablets
01 Apr 2026 //
PR NEWSWIRE
Accord Healthcare Launches Generic Clomid for Ovulatory Disorders
02 Dec 2025 //
PR NEWSWIRE
Accord Healthcare Launches Dehydrated Alcohol Injection
25 Jun 2025 //
PR NEWSWIRE
Accord Healthcare Adds Generic Drug Approved for the Treatment of Relapsing MS
13 Mar 2023 //
PR NEWSWIRE
Accord Healthcare Offers Generic Option for Treatment of Schizophrenia
21 Feb 2023 //
PR NEWSWIRE
Tecfidera (Dimethyl Fumarate) : Biogen vs. Accord Healthcare
14 Feb 2019 //
PATENT LITIGATION
Esbriet® (pirfenidone) : Genentech vs. Accord Healthcare
30 Jan 2019 //
PATENT LITIGATION
Imbruvica (ibrutinib): Pharmacyclics, Janssen Biotech vs. Hetero Labs
24 Nov 2018 //
PATENT LITIGATION
Faslodex (fulvestrant) : AstraZeneca Pharmaceuticals v. Accord Healthcare
27 Aug 2018 //
PATENT LITIGATION
Faslodex¨ (fulvestrant): AstraZeneca v. Accord Healthcare, Inc.
26 Jul 2018 //
PATENT LITIGATION
Gilenya (Fingolimod): Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
18 Jul 2018 //
PATENT LITIGATION
Latuda® (Lurasidone HCl): Sumitomo Dainippon Pharma v. Accord Healthcare
08 Mar 2018 //
PATENT LITIGATION
BMS and Pfizer file 16 Eliquis patent lawsuits to waylay generic makers
13 Apr 2017 //
FIERCE PHARMA
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Wockhardt
10 Apr 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Accord Healthcare
10 Apr 2017 //
PATENT LITIGATION
Mylan to Pay $96.5 Million to Settle Generic Provigil Claims
07 Feb 2017 //
BLOOMBERG
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.